aminocaproic acid has been researched along with Bone Diseases in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Bone Diseases: Diseases of BONES.
Excerpt | Relevance | Reference |
---|---|---|
"Lathyrism has been reviewed in respect to four overlapping phases: finding an animal model for neurolathyrism, characterizing osteolathyrism in respect to its possible use as an animal model for human diseases, such as Marfan's syndrome, idiopathic juvenile scoliosis, etc." | 1.27 | Lathyrism: mini-review and a comment on the lack of effect of protease inhibitors on osteolathyrism. ( Arunatut, O; Buranarugsa, MW; Yeager, VL, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yeager, VL | 1 |
Buranarugsa, MW | 1 |
Arunatut, O | 1 |
1 other study available for aminocaproic acid and Bone Diseases
Article | Year |
---|---|
Lathyrism: mini-review and a comment on the lack of effect of protease inhibitors on osteolathyrism.
Topics: Aminocaproates; Aminocaproic Acid; Aminopropionitrile; Animals; Aprotinin; Bone Diseases; Collagen; | 1985 |